Authors: C. Höschl Authors‘ workplace: Ředitel: prof. MUDr. Cyril Höschl, DrSc., FRCPsych. ; Psychiatrické centrum, Praha Published in: Prakt. Lék. 2010; 90(8): 502-505 Category: Topic/News/Review
In psychiatry, personalised medicine in terms of treatment tailored to the individual patient can currently only be based on the knowledge of the mode of action of psychotropic drugs, their pharmacokinetics, and on predictive tests, e.g., QEEG methods. The use of molecular biology, genomics, and proteomics in psychiatry still lags behind other medical fields.
Key words: personalised medicine, psychiatry, psychopharmacology.
1. Höschl, C. First-generation antipsychotics. In: Stolerman I.P. (ed.), Encyclopaedia of Psychopharmacology. Berlin-Heidelberg: Springer-Verlag, 2010.
2. Burns, M.J. The pharmacology and toxicology of atypical antipsychotic agents. J. Toxicol. Clin. Toxicol. 2001, 39(1), p. 1-14.
3. Horáček, J. a kol. Psychotické stavy v klinické praxi. Praha: Amepra, 2003.
4. Weiden, P.J. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia. J. Clin. Psychiatry 2007, 68, Suppl 4, p. 34-39.
5. Bareš, M., Brunovský, M., Kopeček, M et al. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: A pilot study. J. Psych. Res. 2007, 41(3-4), p. 319-325.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
